Actively Recruiting
Lidocaine Infusion Treatment for Subarachnoid Hemorrhage Headaches
Led by University of Kansas Medical Center · Updated on 2025-07-17
20
Participants Needed
1
Research Sites
178 weeks
Total Duration
On this page
Sponsors
U
University of Kansas Medical Center
Lead Sponsor
A
Ascension Health
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this observational study is to evaluate intravenous lidocaine efficacy and safety in treating headache following non-traumatic subarachnoid hemorrhage. Through this prospective analysis, the investigators hope to: 1. show that intravenous lidocaine infusion causes a clinically significant reduction in pain scores in patients with moderate/severe headache pain following non-traumatic subarachnoid hemorrhage; 2. show that intravenous lidocaine infusion is safe in treating headache following non-traumatic subarachnoid hemorrhage; 3. and report vasospasm prevalence in the cohort. Participants will receive lidocaine infusion as treatment for non-traumatic subarachnoid hemorrhage headache and provide pain scores (on a numeric pain scale) every two hours the patients are awake for a maximum of seven days. Monitoring for vasospasm will occur as part of the patients regular medical care.
CONDITIONS
Official Title
Lidocaine Infusion Treatment for Subarachnoid Hemorrhage Headaches
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients over 18 years old
- Have a favorable neurological status with Hunt and Hess score 3 or less
- Can communicate numeric pain scores
- Diagnosed with non-traumatic subarachnoid hemorrhage
You will not qualify if you...
- Diagnosed with traumatic subarachnoid hemorrhage
- Under 18 years of age
- Unable to provide numeric pain scores for more than 3 days during hospitalization
- Had a prior aneurysm
- Have chronic pain unrelated to non-traumatic subarachnoid hemorrhage
- Have a disability before the stroke with modified Rankin Scale score greater than 2
- Have a Hunt and Hess score greater than 3
- Have contraindications to lidocaine such as significant cardiac disease, arrhythmia, seizures, or previous allergic reaction to lidocaine
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ascension Via Christi St. Francis
Wichita, Kansas, United States, 67214
Actively Recruiting
Research Team
W
William L Krogman, MS
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here